Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Quattro74on Aug 19, 2020 3:17pm

213 Views

Post# 31430173

SRA Sponsored Research Agreement

So this is on the Uni's dime then, TLT has already demonstrated this tech in the test tube, just needed a partner. Now because of Covid 19 we have one(?) or maybe there will be more partners? This also gives them a way to showcase their ACT, in particular the Vaccine part. Hope all goes well and they can announce good findings in the next few weeks/months.

Bullboard Posts

Debt-free cannabis company set for next stage of growth